 |
BOS cmc 2017 website | View Programme | View Attendee List
|
|
In just 6 weeks time R&D professionals from across Europe will come together for Biotech Outsourcing Strategies cmc 2017 in Basel, Switzerland. The focus for the event is development stage CMC outsourcing for both small molecules and biologics. Our programme scope includes outsourcing of drug substance, analytical development, drug product and drug delivery technologies. Please find details below outlining programme highlights. To view the full programme please click here.
|
|
Featured Presentation - BOS cmc 2017
|
|
Dr Jorgen Wittendorff
Senior Director, CMC Manufacturing & Supply, Ablynx nv
How to use QbD to guide process strategy for late phase outsourced biomanufacturing – a practical example.
|
 |
|
Dr Firelli Alonso
Senior Director, External Supply (BioTherapeutics), Pfizer
Cell and Gene Therapy Supply Chain: Not Mission Impossible?
|
|
Dr Jesper Valbjørn
Vice President CMC, Genmab A/S
Optimising biologics outsourcing in early development - the journey of an SME biotech.
|
|
Dr Ulrich Rümenapp
Head of Launch Preparation and Coordination, Biological Development, Bayer Pharma AG
Designing and executing a biologics outsourcing process.
|
|
Dr Andrea Calenne
Senior Manager External Manufacturing, Biogen
Managing communication within tech transfer: balancing effectiveness, quality of deliverables and stakeholder objectives.
|
|
Dr Lidia Cappellina
Head of Outsourcing Management, CHIESI FARMACEUTICI S.P.A.
Evaluating costs, benefit, risks and rewards of CMC outsourcing strategies.
|
|
Dr Chris Davies
Sourcing Project Manager, AstraZeneca.
Early Phase Drug Substance Outsourcing Strategy.
|
|
Dr Joslyn Brunelle
Product Quality Team Leader, FDA (Office of Biotechnology Products OBP)
View from the regulator- recommendations for comparability studies to support manufacturing changes.
|
|
1 to 1 Meetings Via Partnering Software: Established in 2008, Biotech Outsourcing Strategies cmc is a forum where relationships are forged and business is done. All attendees have access to the BOS Events partnering software, this presents a platform for biotech and pharma to outline the capabilities they require and CMOs the opportunity to respond in kind. Partnering takes place in parallel to the presentations and offers a highly effective mechanism for outsourcing parties to come together.
Peer to Peer networking: BOS cmc 2017 offers you the opportunity to connect with peers in the industry who share the same challenges as you. We have structured the 2 day event to give you plenty of opportunities to touch base with old faces and new faces over coffee or lunch.
We hope you will be able to join us in Basel.
If you would like to register for this event please click here to view pricing and access online registration.
|
 |
CLICK HERE TO UNSUBSCRIBE
|
www.pharmaceutical-tech.com - A product of Ochre Media Pvt. Ltd.
|
